Published on 09/18/2025 at 03:41 am EDT
(MT Newswires) -- Chinese stocks retreated Thursday after the country's central bank refused to follow the lead of the US Federal Reserve, which slashed its interest rate for the first time in 2025.
The Shanghai Composite Index, the main gauge of Chinese stocks, slid 1.2% or by 44.68 points to 3,831.66. The Shenzhen Component Index declined 1.1% or by 139.80 points to 13,075.66.
The US Federal Reserve reduced its benchmark interest rate by 0.25 percentage points to the 4% to 4.25% range, a move the Fed Chairman Jerome Powell said is a "risk management cut."
In a press briefing, Powell said the benchmark rate could fall further in October and December, Reuters reported separately.
Amid the Fed cut, the People's Bank of China injected 487 billion yuan in seven-day reverse repurchase operations with a seven-day term and an interest of 1.4%.
Despite the overall economic slowdown, resilient exports have helped Chinese policymakers to pause fresh stimulus, Reuters reported separately Thursday.
"Although the economy is slowing as expected, the magnitude of the deceleration appears not as big as we assumed," Reuters quoted Goldman Sachs China Chief Economist Hui Shan as saying.
On the corporate front, Mabwell (Shanghai) Bioscience (SHA:688062) surged 13% at market close after it granted Kalexo exclusive rights to develop, manufacture, and commercialize the 2MW7141 dyslipidemia drug.
Sumber : MT Newswires
作者:indopremier_id,文章来源indopremier_id,版权归原作者所有,如有侵权请联系本人删除。
风险提示:本文所述仅代表作者个人观点,不代表 Followme 的官方立场。Followme 不对内容的准确性、完整性或可靠性作出任何保证,对于基于该内容所采取的任何行为,不承担任何责任,除非另有书面明确说明。
喜欢的话,赞赏支持一下
加载失败()